Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Goldman Myla Lai currently holds 16,391 shares of LABORATORY CORP OF AMERICA HOLDINGS (LH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Goldman Myla Lai has been a net seller of LH stock. They have purchased $118.4K and sold $17.9M worth of shares.
Goldman Myla Lai's most recent insider trade was on Jul 8, 2026, when they sold 8,073 shares at $0.00 per share.
Goldman Myla Lai serves as Executive at LABORATORY CORP OF AMERICA HOLDINGS (LH). They have executed 349 insider transactions totaling $18.0M over their tenure at the company.
Goldman Myla Lai holds the position of Executive at LABORATORY CORP OF AMERICA HOLDINGS, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Goldman Myla Lai has shown a selling trading pattern, with $118.4K in total purchases and $17.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Goldman Myla Lai was on Mar 26, 2008, when they sold $1.3M worth of LH shares. This transaction involved 18,052 shares at $74.50 per share.
Goldman Myla Lai currently owns 16,391 shares of LABORATORY CORP OF AMERICA HOLDINGS (LH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Goldman Myla Lai's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Goldman Myla Lai has 349 Form 4 filings on record as an insider at LABORATORY CORP OF AMERICA HOLDINGS.
Set alerts for Goldman Myla Lai and 40,000+ other insiders.